Quince Therapeutics Inc. logo

Quince Therapeutics Inc.

QNCX | NASDAQ
Chart Builder DCF Calculator
$31.35
+$0.35 (+1.13%)
Sep 22, 2026, 1:32 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
5.81M 6.21M 20.75M 44.58M 69.72M 66.84M
Short-Term Investments
11.94M 34.57M 54.31M 45.6M 37.08M 66.98M
Long-Term Investments
78K 78K 78K 3.58M 19.93M 50.46M
Other Long-Term Assets
1.68M 9.51M 8.47M 3.58M 194K 39K
Receivables
3.62M 882K 993K n/a 1.13M n/a
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
54K 84K 81K 2.37M 367K 694K
Total Current Assets
22.9M 44.04M 77.44M 93.75M 111.67M 137.86M
Property-Plant & Equipment
1.05M 813K 619K 684K 1.43M 1.1M
Goodwill & Intangibles
67.82M 60.05M 81.3M 5.9M n/a n/a
Total Long-Term Assets
70.63M 70.44M 102.76M 10.16M 21.56M 51.6M
Total Assets
93.52M 114.48M 180.2M 103.91M 133.23M 189.47M
Account Payables
2.22M 2.9M 2.03M 570K 4.91M 3.56M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
18.03M n/a 64K n/a n/a n/a
Other Current Liabilities
12.58M 308K 5.14M 916K 180K 10.79M
Total Current Liabilities
43.23M 7.28M 9.57M 3.07M 14.22M 17M
Long-Term Debt
330K 14.32M 13.43M n/a n/a n/a
Other Long-Term Liabilities
85.68M 57.38M 54.19M n/a n/a n/a
Total Long-Term Liabilities
86.01M 77.05M 85.55M 248K 420K 208K
Total Liabilities
129.24M 84.33M 95.12M 3.32M 14.64M 17.2M
Total Debt
18.47M 14.81M 13.81M 453K 1.16M 446K
Book Value
-35.71M 30.15M 85.08M 100.59M 118.59M 172.26M
Book Value Per Share
-142.58 139.36 456.98 600.62 798.06 1.18K
Common Stock
55K 44K 43K 36K 30K 29K
Retained Earnings
-460.45M -376.47M -319.64M -288.26M -236.6M -146.65M
Comprehensive Income
5.75M -35K 3.05M -289K -79K 313K
Shareholders Equity
-35.71M 30.15M 85.08M 100.59M 118.59M 172.26M
Total Investments
12.02M 34.65M 54.39M 49.18M 57.01M 117.44M

© 2026 bestshares.com. All rights reserved.